Altris AI, a Chicago, IL-based AI-diagnostics startup, raised $1M in funding.
The round was led by Runa Capital with participation from Joint Journey, Pharmaceutical Company Farmak, Artesian, Brinc Limited, University of Chicago Booth School of Business and Chicago Booth Angels.
The company intends to use the funds to scale its AI-enabled eye care diagnostics solution.
Led by Founder and CEO Andrey Kuropyatnyk, Altris AI is developing an AI platform that assists eye care professionals in fighting blindness. The platform can detect over 100 pathologies, including age-related macular degeneration, glaucoma or choroidal nevus. Its medical image management platform is already installed in more than 30 clinics, with over 11000+ ophthalmologists and optometrists using its free educational mobile app. Altris AI already partners with global OCT distributors and equipment manufacturers such as Topcon Healthcare, Optopol, and Huvitz.
The company is headquartered in the USA with its R&D centers located in Kyiv, Ukraine, and Malaga, Spain.
FinSMEs
15/12/2022